A Study to Assess the Safety and Efficacy of 3 Doses of ALX1-11 (50, 75, and 100µg) in the Treatment of Postmenopausal Osteoporosis
Clinical trial NCT00172107 · COMPLETED
Trial details
- NCT number
- NCT00172107
- Sponsor
- Shire
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1995-05-18
- Primary completion
- 1997-03-24
- Enrollment
- 217
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.